Press release
Erdosteine Market Research Report 2024
Erdosteine is an oral mucolytic agent used for treatment of chronic obstructive bronchitis. Erdosteine is also used for treatment of acute and chronic bronchitis. It is an orphan drug. Erdosteine stimulates mucus production and increases mucociliary transport, which improves expectoration. It consists of two sulfhydryl groups freed after metabolic transformation in the liver. These released sulfhydryl groups help to break the disulphide bonds. This makes bronchial secretions more fluid and enhances elimination. Erdosteine shows inhibitory activity against the effects of free radicals produced by cigarette smoke. Pharmacokinetically, it acts by absorption, distribution, metabolism, and excretion. The elimination half-life of Erdosteine is about 1.46 hr. Adverse events of Erdosteine are quite low, and generally mild. It has been clinically proven that Erdosteine has good gastric tolerability after oral administration, and does not cause reflux phenomena like other thiols derivatives. Erdosteine has no direct effect on gastric mucus.View Report @ http://www.transparencymarketresearch.com/erdosteine-market.html
Increasing prevalence of respiratory diseases, rising geriatric population, rapid population growth, and environmental pollution due to industrialization are expected to fuel the global erdosteine market. According to the WHO, chronic obstructive pulmonary disease (COPD) accounts for three million deaths globally each year and the number is expected to increase in the next few years. About 90% of chronic obstructive pulmonary disease (COPD) deaths occur in developing and underdeveloped countries. Rising research and development activities, increasing health care insurance coverage, and growing adoption for treatment options are the other factors driving the global erdosteine market. On the other hand, stringent regulations for product approval are likely to hamper the growth of the global erdosteine market. Erdosteine is used for rare diseases so maximum companies doing research and development which will increase the market competitiveness. Erdosteine is marketed in over 40 countries for the treatment of various respiratory diseases.
The erdosteine market has been segmented based on dosage form, age group, application, distribution channel, and region. In terms of dosage form, the market has been classified into capsules, dry suspension, dispersible tablets, and sachets. The capsule dosage form is highly used due to ease of use, availability in unit dosage form, and also easy in term of prescription scenario which will leads to less side effect. Based on age group, the erdosteine market has been segmented into adult and pediatric. In terms of application, the market has been classified into chronic obstructive pulmonary disease (COPD), acute bronchitis (AB), and chronic bronchitis (CB). Based on distribution channel, the erdosteine market has been categorized into hospital pharmacies, retail pharmacies, and online pharmacies.
In terms of region, the market has been segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Get accurate market forecast and analysis on the Erdosteine Market. Request a sample to stay abreast on the key trends impacting this market.
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=19166
North America dominated the erdosteine market due to rising geriatric population, early adoption of treatment procedures, and increasing prevalence of respiratory diseases. The geriatric population represents about 14.5% of the population of the U.S. According to the U.S. Department of Health and Human Service, the geriatric population will increase to 98 million by 2060, which is twice that in 2014. Europe is the second largest market for erdosteine attributed to increasing research and development activities and rising number of commercial licensing partnerships for erdosteine manufacturing. Asia Pacific is expected to grow at a higher rate driven by growing per capita expenditure, increasing health care insurance coverage, rapidly growing population, and rising per capita health care expenditure.
Major players operating in the erdosteine market include Edmond Pharma S.R.L., Alitair Pharmaceuticals, Manus Aktteva Biopharma LLP, Enaltec, Reine Life Science, Taj Pharmaceuticals Ltd., Recipharm AB, Glenmark Pharmaceuticals Ltd., Sigma-Aldrich Co. LLC, Genome Pharmaceuticals (Pvt.) Ltd., and Milan Pharma.
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Erdosteine Market Research Report 2024 here
News-ID: 544323 • Views: …
More Releases from Transparency Market Research

Multispace Parking Meter Market to Reach USD 1 Billion by 2031, Growing at a CAG …
The multispace parking meter market is witnessing strong growth, fueled by rapid urbanization, rising vehicle ownership, and the increasing demand for efficient parking management solutions. These advanced meters allow multiple vehicles to park within a designated area using a unified payment system, offering greater convenience for users and improved operational efficiency for municipalities and parking operators.
The Multispace Parking Meter Market is projected to reach approximately USD 1 billion by the…

Handheld Digital Multimeter Market Set for Steady Growth, Projected to Hit USD 8 …
The handheld digital multimeter (DMM) market is gaining momentum, driven by the growing need for portable and high-precision testing tools across multiple industries. These devices play a critical role in measuring electrical parameters such as voltage, current, and resistance, making them vital in fields like electronics, automotive diagnostics, energy systems, and industrial maintenance. Their ease of use, compact design, and evolving feature sets continue to boost adoption among both professionals…

Explosive Growth Ahead: Chiplets Market to Reach USD 46.47 Billion by 2034, Driv …
The Chiplets Market represents a transformative shift in semiconductor design and manufacturing. Instead of building complex integrated circuits as a single monolithic chip, the chiplets approach breaks them into smaller, functional modules that can be independently developed, manufactured, and tested. These chiplets are then integrated into a unified package, enabling greater flexibility, improved performance, faster time-to-market, and cost-effective customization. This modular strategy is rapidly gaining traction across high-performance computing, AI,…

System Integration Services Market Set for Steady Growth, Reaching USD 52.3 Bill …
The System Integrator Market plays a crucial role in enabling businesses to integrate various components of their IT and operational systems seamlessly. These integrators design, implement, and manage complex systems by combining hardware, software, and networking solutions, providing customized services to meet specific industry needs. The market has witnessed significant growth, driven by the increasing adoption of advanced technologies and the need for streamlined processes across industries.
System Integrator market is…
More Releases for Erdosteine
Erdosteine Market Global Industry Analysis and Forecast Till 2024
Erdosteine is an oral mucolytic agent used for treatment of chronic obstructive bronchitis. Erdosteine is also used for treatment of acute and chronic bronchitis. It is an orphan drug. Erdosteine stimulates mucus production and increases mucociliary transport, which improves expectoration. It consists of two sulfhydryl groups freed after metabolic transformation in the liver. These released sulfhydryl groups help to break the disulphide bonds. This makes bronchial secretions more fluid and…
Erdosteine Market Global Industry Analysis and Trends till 2024
Erdosteine is an oral mucolytic agent used for treatment of chronic obstructive bronchitis. Erdosteine is also used for treatment of acute and chronic bronchitis. It is an orphan drug. Erdosteine stimulates mucus production and increases mucociliary transport, which improves expectoration. It consists of two sulfhydryl groups freed after metabolic transformation in the liver. These released sulfhydryl groups help to break the disulphide bonds. This makes bronchial secretions more fluid and…
Erdosteine Market: Future market projections for forthcoming years
Erdosteine is an oral mucolytic agent used for treatment of chronic obstructive bronchitis. Erdosteine is also used for treatment of acute and chronic bronchitis. It is an orphan drug. Erdosteine stimulates mucus production and increases mucociliary transport, which improves expectoration. It consists of two sulfhydryl groups freed after metabolic transformation in the liver. These released sulfhydryl groups help to break the disulphide bonds. This makes bronchial secretions more fluid and…
Erdosteine Market - Trends And Opportunities For The Industry By 2024
Erdosteine is an oral mucolytic agent used for treatment of chronic obstructive bronchitis. Erdosteine is also used for treatment of acute and chronic bronchitis. It is an orphan drug. Erdosteine stimulates mucus production and increases mucociliary transport, which improves expectoration. It consists of two sulfhydryl groups freed after metabolic transformation in the liver. These released sulfhydryl groups help to break the disulphide bonds. This makes bronchial secretions more fluid and…
Global Erdosteine Tablets Market Size, Status and Forecast 2021
The report on the Erdosteine Tablets market gives a meticulous introduction about the Erdosteine Tablets market in the intial part of the report and further the information such as emerging trends, regional markets, application, policy analysis, end-users, and value chain structure are discussed. The report contains complete details about global the market, which comprises the past market scenario, the current situation of the market, and the future conditions forecasted. The…
Erdosteine Market 2024 Analysis & Trends by Types and Application
Erdosteine is an oral mucolytic agent used for treatment of chronic obstructive bronchitis. Erdosteine is also used for treatment of acute and chronic bronchitis. It is an orphan drug. Erdosteine stimulates mucus production and increases mucociliary transport, which improves expectoration. It consists of two sulfhydryl groups freed after metabolic transformation in the liver. These released sulfhydryl groups help to break the disulphide bonds. This makes bronchial secretions more fluid and…